Validating Baboon Ex Vivo and in Vivo Radiation-Related Gene Expression with Corresponding Human Data

M. Port, M. Majewski, F. Herodin, M. Valente, M. Drouet, F. Forcheron, A. Tichy, I. Sirak, A. Zavrelova, A. Malkova, B. V. Becker, D. A. Veit, S. Waldeck, Christophe Badie, G. O'Brien, H. Christiansen, J. Wichmann, M. Eder, G. Beutel, J. VachelovaS. Doucha-Senf, M. Abend*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Abstract

The research for high-throughput diagnostic tests for victims of radio/nuclear incidents remains ongoing. In this context, we have previously identified candidate genes that predict risk of late-occurring hematologic acute radiation syndrome (HARS) in a baboon model. The goal of the current study was to validate these genes after radiation exposure in humans. We also examined ex vivo relative to in vivo measurements in both species and describe dose-response relationships. Eighteen baboons were irradiated in vivo to simulate different patterns of partial- or total-body irradiation (TBI), corresponding to an equivalent dose of 2.5 or 5 Sv. Human in vivo blood samples were obtained from patients exposed to different dose ranges: diagnostic computerized tomography (CT; 0.004-0.018 Sv); radiotherapy for prostate cancer (0.25-0.3 Sv); and TBI of leukemia patients (2 × 1.5 or 2 × 2 Sv, five patients each). Peripheral whole blood of another five baboons and human samples from five healthy donors were cultivated ex vivo and irradiated with 0-4 Sv. RNA was isolated pairwise before and 24 h after irradiation and converted into cDNA. Gene expression of six promising candidate genes found previously by us in a baboon model (WNT3, POU2AF1, CCR7, ARG2, CD177, WLS), as well as three genes commonly used in ex vivo whole blood experiments (FDXR, PCNA, DDB2) was measured using qRT-PCR. We confirmed the six baboon candidate genes in leukemia patients. However, expression for the candidate gene FDXR showed an inverse relationship, as it was downregulated in baboons and upregulated in human samples. Comparisons among the in vivo and ex vivo experiments revealed the same pattern in both species and indicated peripheral blood cells to represent the radiation-responsive targets causing WNT3 and POU2AF1 gene expression changes. CCR7, ARG2, CD177 and WLS appeared to be altered due to radiation-responsive targets other than the whole blood cells. Linear dose-response relationships of FDXR, WNT3 and POU2AF1 using human ex vivo samples corresponded with human in vivo samples, suggesting that ex vivo models for in vivo dose estimates can be used over a wide dose range (0.001-5 Sv for POU2AF1). In summary, we validated six baboon candidate genes in humans, but the FDXR measurements underscored the importance of independent assessments even when candidates from animal models have striking gene sequence homology to humans. Since whole blood cells represented the same radiation-responsive targets for FDXR, WNT3 and POU2AF1 gene expression changes, ex vivo cell culture models can be utilized for in vivo dose estimates over a dose range covering up to 3.5 log scales. These findings might be a step forward in the development of a gene expression-based high-throughput diagnostic test for populations involved in large-scale radio/nuclear incidents.

Original languageEnglish
Pages (from-to)389-398
Number of pages10
JournalRadiation Research
Volume189
Issue number4
DOIs
Publication statusPublished - Apr 2018

Bibliographical note

Funding Information:
We are grateful for the valuable support of Daniela Garve and Anke Breithaupt from the Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation of the Hannover Medical School. We appreciate the sophisticated and carefully performed technical assistance of Eva Grumpelt. This work was supported by the Ministry of Defense of the Czech Republic (long-term organization development plan Medical Aspects of Weapons of Mass Destruction of the Faculty of Military Health Sciences, University of Defense), the Radiation Team of the Newcastle University and Public Health of England, Health Protection Research Unit (HPRU), research project PROGRES Q40/08. This work was also supported by the French and German Ministries of Defense.

Publisher Copyright:
© 2018 by Radiation Research Society.

Fingerprint

Dive into the research topics of 'Validating Baboon Ex Vivo and in Vivo Radiation-Related Gene Expression with Corresponding Human Data'. Together they form a unique fingerprint.

Cite this